Handel PLx Pharma Inc. - PLXP CFD
Føj til favorit- Opsummering
- Historisk Data
- Begivenheder
- Resultatopgørelse
- Saldo
- Cash flow
- Ejerskab
Spænd | 0.05 | ||||||||
Long position, gebyr natten over
Long position overnight fee
Gå til platform | -0.024068% | ||||||||
Short position, gebyr natten over
Short position overnight fee
Gå til platform | 0.001846% | ||||||||
Gebyr natten over, tid | 21:00 (UTC) | ||||||||
Min. handlet mængde | 1 | ||||||||
Valuta | USD | ||||||||
Margen | 20% | ||||||||
Aktiebørs | United States of America | ||||||||
Kommission på handel | 0% |
*Information provided by Capital.com
Tidligere luk* | 0.58 |
Åben* | 0.54 |
1-Års Ændring* | 42.11% |
Dagens Spænd* | 0.38 - 0.54 |
52-Ugers Spænd | 0.12-4.43 |
Gennemsnitlig Volumen (10 dage) | 276.45K |
Gennemsnitlig Volumen (3 måneder) | 7.97M |
Market Cap | 4.43M |
P/E-forhold | -100.00K |
Udestående aktier | 29.14M |
Omsætning | 4.54M |
EPS | -0.99 |
Dividend (Udbytte %) | N/A |
Beta | 3.85 |
Næste indtjeningsopgørelse | Mar 28, 2023 |
Al data kommer fra Refinitiv, med undtagelse af data markeret med en asterisk, som er *data fra Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Luk | Change | Change (%) | Åben | High | Low |
---|---|---|---|---|---|---|
Nov 11, 2022 | 0.38 | -0.16 | -29.63% | 0.54 | 0.54 | 0.38 |
Nov 10, 2022 | 0.58 | -0.02 | -3.33% | 0.60 | 0.60 | 0.57 |
Nov 9, 2022 | 0.57 | 0.00 | 0.00% | 0.57 | 0.59 | 0.57 |
Nov 8, 2022 | 0.58 | -0.02 | -3.33% | 0.60 | 0.60 | 0.57 |
Nov 7, 2022 | 0.63 | 0.07 | 12.50% | 0.56 | 0.63 | 0.56 |
Nov 4, 2022 | 0.60 | -0.01 | -1.64% | 0.61 | 0.67 | 0.56 |
Nov 3, 2022 | 0.61 | 0.03 | 5.17% | 0.58 | 0.62 | 0.58 |
Nov 2, 2022 | 0.58 | 0.00 | 0.00% | 0.58 | 0.61 | 0.57 |
Nov 1, 2022 | 0.58 | 0.00 | 0.00% | 0.58 | 0.59 | 0.57 |
Oct 31, 2022 | 0.59 | 0.00 | 0.00% | 0.59 | 0.60 | 0.57 |
Oct 28, 2022 | 0.58 | 0.02 | 3.57% | 0.56 | 0.60 | 0.56 |
Oct 27, 2022 | 0.56 | 0.00 | 0.00% | 0.56 | 0.57 | 0.56 |
Oct 26, 2022 | 0.57 | 0.03 | 5.56% | 0.54 | 0.57 | 0.54 |
Oct 25, 2022 | 0.53 | -0.02 | -3.64% | 0.55 | 0.56 | 0.52 |
Oct 24, 2022 | 0.58 | 0.00 | 0.00% | 0.58 | 0.60 | 0.58 |
Oct 21, 2022 | 0.58 | 0.00 | 0.00% | 0.58 | 0.60 | 0.58 |
Oct 20, 2022 | 0.58 | 0.00 | 0.00% | 0.58 | 0.60 | 0.58 |
Oct 19, 2022 | 0.58 | 0.01 | 1.75% | 0.57 | 0.61 | 0.57 |
Oct 18, 2022 | 0.57 | -0.02 | -3.39% | 0.59 | 0.59 | 0.55 |
Oct 17, 2022 | 0.56 | 0.03 | 5.66% | 0.53 | 0.59 | 0.53 |
PLx Pharma Inc. Events
Tid (UTC) (UTC) | Land | Begivenhed |
---|---|---|
No events scheduled |
- Årlig
- Pr kvartal
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Total omsætning | 8.208 | 0.03043 | 0.56546 | 0.75311 | 0.77866 |
Omsætning | 8.208 | 0.03043 | 0.56546 | 0.75311 | 0.77866 |
Totale Driftsudgifter | 48.998 | 13.4895 | 14.7678 | 11.7143 | 16.6265 |
Salgs/Generelle/Admin. Udgifter, Total | 40.011 | 9.15057 | 10.0266 | 7.7916 | 10.175 |
Forskning & Udvikling | 4.182 | 4.33897 | 4.74113 | 3.92267 | 4.15745 |
Usædvanlig Udgift (Indkomst) | 0 | 2.29405 | |||
Driftsindtægter | -40.79 | -13.4591 | -14.2023 | -10.9612 | -15.8478 |
Renteindkomst (Udgift), Netto Ikke-Drift | -5.335 | -1.75154 | -6.3001 | 11.8576 | -0.41889 |
Netto Indkomst Før Skat | -46.125 | -15.2107 | -20.5024 | 0.89648 | -16.2667 |
Netto Indkomst Efter Skat | -46.125 | -15.2107 | -20.5024 | 0.89648 | -15.3467 |
Netto Indkomst Før Ekstra Ting | -46.125 | -15.2107 | -20.5024 | 0.89648 | -15.3467 |
Netto Indkomst | -46.125 | -15.2107 | -20.5024 | 0.89648 | -15.3467 |
Indkomst Tilgængelig for Almindelige Uden Ekstra Ting | -48.65 | -16.948 | -34.2532 | 0.89648 | -15.3467 |
Indkomst Tilgængelig for Almindelige Uden Ekstra Ting | -48.65 | -16.948 | -34.2532 | 0.89648 | -15.3467 |
Fortyndet Netto Indkomst | -48.65 | -16.948 | -34.2532 | 0.89648 | -15.3467 |
Fortyndet Vægtet Gennemsnit Aktier | 23.6505 | 9.71495 | 8.91619 | 8.73322 | 7.02048 |
Fortyndet EPS Uden Ekstraordinære Ting | -2.05704 | -1.74452 | -3.84169 | 0.10265 | -2.18599 |
Fortyndet Normaliseret EPS | -2.05704 | -1.74452 | -3.84169 | 0.10265 | -1.9736 |
Total Adjustments to Net Income | -2.525 | -1.7373 | -13.7508 | ||
Kost af omsætning, Total | 4.805 | ||||
Bruttofortjeneste | 3.403 |
Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | |
---|---|---|---|---|---|
Total omsætning | 0.386 | 0.483 | 2.083 | 1.5919 | 6.6161 |
Omsætning | 0.386 | 0.483 | 2.083 | 1.5919 | 6.6161 |
Totale Driftsudgifter | 11.225 | 15.021 | 20.279 | 22.4437 | 16.4779 |
Salgs/Generelle/Admin. Udgifter, Total | 9.142 | 13.645 | 18.456 | 20.8637 | 11.0132 |
Forskning & Udvikling | 0.623 | 0.556 | 0.654 | 0.68778 | 1.55199 |
Driftsindtægter | -10.839 | -14.538 | -18.196 | -20.8518 | -9.86185 |
Renteindkomst (Udgift), Netto Ikke-Drift | 2.342 | 2.68 | 7.411 | 24.4142 | -11.7807 |
Netto Indkomst Før Skat | -8.497 | -11.858 | -10.785 | 3.56237 | -21.6425 |
Netto Indkomst Efter Skat | -8.497 | -11.858 | -10.785 | 3.56237 | -21.6425 |
Netto Indkomst Før Ekstra Ting | -8.497 | -11.858 | -10.785 | 3.56237 | -21.6425 |
Netto Indkomst | -8.497 | -11.858 | -10.785 | 3.56237 | -21.6425 |
Total Adjustments to Net Income | 0 | 0 | 0 | -0.00004 | 0 |
Indkomst Tilgængelig for Almindelige Uden Ekstra Ting | -8.497 | -11.858 | -10.785 | 3.56233 | -21.6425 |
Indkomst Tilgængelig for Almindelige Uden Ekstra Ting | -8.497 | -11.858 | -10.785 | 3.56233 | -21.6425 |
Fortyndet Netto Indkomst | -8.497 | -11.858 | -10.785 | 3.56233 | -21.6425 |
Fortyndet Vægtet Gennemsnit Aktier | 28.6034 | 27.6935 | 27.5392 | 27.5742 | 26.9119 |
Fortyndet EPS Uden Ekstraordinære Ting | -0.29706 | -0.42819 | -0.39162 | 0.12919 | -0.8042 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
Fortyndet Normaliseret EPS | -0.29706 | -0.42819 | -0.39162 | 0.12919 | -0.8042 |
Kost af omsætning, Total | 1.46 | 0.82 | 1.169 | 0.89226 | 3.91274 |
Bruttofortjeneste | -1.074 | -0.337 | 0.914 | 0.69964 | 2.70336 |
- Årlig
- Pr kvartal
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Totale Nuværende Aktiver | 73.476 | 22.9855 | 14.2833 | 14.8654 | 25.69 |
Likvider og Kortsigtede Investeringer | 69.392 | 22.4487 | 14.0013 | 14.2503 | 24.4044 |
Likvider & Lignende | 69.392 | 22.4487 | 14.0013 | 14.2503 | 24.4044 |
Totale Tilgodehavender, Netto | 0.634 | 0 | 0.01868 | 0.01823 | 0.01938 |
Accounts Receivable - Trade, Net | 0.634 | 0 | 0.01868 | 0.01823 | 0.01938 |
Total Inventory | 2.458 | 0.14338 | 0 | 0.24637 | |
Prepaid Expenses | 0.992 | 0.39347 | 0.26327 | 0.40937 | 0.30017 |
Other Current Assets, Total | 0 | 0.18754 | 0.71967 | ||
Total Assets | 76.642 | 26.6166 | 18.5028 | 18.3884 | 28.8486 |
Property/Plant/Equipment, Total - Net | 1.088 | 1.55304 | 2.0848 | 1.39423 | 1.02988 |
Goodwill, Net | 2.061 | 2.06102 | 2.06102 | 2.06102 | 2.06102 |
Intangibles, Net | |||||
Other Long Term Assets, Total | 0.017 | 0.01704 | 0.07367 | 0.06771 | 0.06771 |
Total Current Liabilities | 11.879 | 3.54231 | 6.09343 | 4.73266 | 1.81569 |
Payable/Accrued | 10.6 | 0.86257 | 0.92892 | 0.65305 | 0.85216 |
Accrued Expenses | 1.278 | 2.02327 | 1.50639 | 1.1699 | 0.96354 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 24.962 | 16.1636 | 16.9331 | 11.9441 | 24.2322 |
Total Long Term Debt | 0 | 0 | 0.62227 | 4.28039 | 6.94215 |
Other Liabilities, Total | 13.083 | 12.6213 | 10.2174 | 2.93104 | 15.4743 |
Total Equity | 51.68 | 10.453 | 1.56962 | 6.44429 | 4.61639 |
Common Stock | 0.028 | 0.01391 | 0.00916 | 0.00874 | 0.00872 |
Additional Paid-In Capital | 183.912 | 91.203 | 74.8371 | 72.8713 | 71.9399 |
Retained Earnings (Accumulated Deficit) | -148.274 | -102.149 | -86.9382 | -66.4358 | -67.3323 |
Total Liabilities & Shareholders’ Equity | 76.642 | 26.6166 | 18.5028 | 18.3884 | 28.8486 |
Total Common Shares Outstanding | 27.5392 | 13.9116 | 9.15626 | 8.74395 | 8.72282 |
Property/Plant/Equipment, Total - Gross | 1.553 | 2.00154 | 2.52769 | 1.68631 | 1.479 |
Accumulated Depreciation, Total | -0.465 | -0.4485 | -0.44288 | -0.29208 | -0.44912 |
Long Term Debt | 0 | 0.62227 | 4.28039 | 6.94215 | |
Current Port. of LT Debt/Capital Leases | 0 | 0.62227 | 3.65812 | 2.90971 | |
Preferred Stock - Non Redeemable, Net | 16.014 | 21.3849 | 13.6616 | ||
Other Current Liabilities, Total | 0.001 | 0.03421 | |||
Total Preferred Shares Outstanding | 0.01501 | 0.023 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Totale Nuværende Aktiver | 57.748 | 73.476 | 88.6142 | 82.013 | 84.8674 |
Likvider og Kortsigtede Investeringer | 52.499 | 69.392 | 82.5543 | 80.1695 | 84.4235 |
Likvider & Lignende | 52.499 | 69.392 | 82.5543 | 80.1695 | 84.4235 |
Total Inventory | 3.839 | 2.458 | 2.19035 | 1.26248 | 0.14338 |
Prepaid Expenses | 0.712 | 0.992 | 0.61625 | 0.58101 | 0.30056 |
Total Assets | 60.858 | 76.642 | 91.8361 | 85.3085 | 88.3209 |
Property/Plant/Equipment, Total - Net | 1.032 | 1.088 | 1.14378 | 1.21751 | 1.37546 |
Goodwill, Net | 2.061 | 2.061 | 2.06102 | 2.06102 | 2.06102 |
Other Long Term Assets, Total | 0.017 | 0.017 | 0.01704 | 0.01704 | 0.01704 |
Total Current Liabilities | 13.23 | 11.879 | 7.40538 | 3.06477 | 1.40919 |
Payable/Accrued | 12.716 | 10.6 | 6.45217 | 2.38232 | 0.96261 |
Accrued Expenses | 0.51113 | 1.278 | 0.95321 | 0.64824 | 0.41238 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 0 | 0 | 0 | 0 | |
Other Current Liabilities, Total | 0.00287 | 0.001 | 0.03421 | 0.03421 | |
Total Liabilities | 18.875 | 24.962 | 44.9288 | 29.1794 | 22.2751 |
Total Long Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Liabilities, Total | 5.645 | 13.083 | 37.5234 | 26.1146 | 20.8659 |
Total Equity | 41.983 | 51.68 | 46.9073 | 56.1292 | 66.0459 |
Preferred Stock - Non Redeemable, Net | 16.014 | 16.014 | 16.0136 | 16.0136 | 21.3849 |
Common Stock | 0.028 | 0.028 | 0.02748 | 0.02615 | 0.02284 |
Additional Paid-In Capital | 185 | 183.912 | 182.702 | 170.283 | 158.327 |
Retained Earnings (Accumulated Deficit) | -159.059 | -148.274 | -151.836 | -130.194 | -113.689 |
Total Liabilities & Shareholders’ Equity | 60.858 | 76.642 | 91.8361 | 85.3085 | 88.3209 |
Total Common Shares Outstanding | 27.5392 | 27.5392 | 27.477 | 26.145 | 22.8363 |
Total Preferred Shares Outstanding | 0.01501 | 0.01501 | 0.01501 | 0.01501 | 0.023 |
Totale Tilgodehavender, Netto | 0.698 | 0.634 | 3.25331 | ||
Accounts Receivable - Trade, Net | 0.698 | 0.634 | 3.25331 |
- Årlig
- Pr kvartal
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Netto indkomst/Startlinje | -46.125 | -15.2107 | -20.5024 | 0.89648 | -15.3467 |
Likvider Fra Driftsaktiviteter | -32.118 | -12.2436 | -12.659 | -9.49923 | -13.3066 |
Likvider Fra Driftsaktiviteter | 0.116 | 0.12462 | 0.15825 | 0.20096 | 0.02984 |
Deferred Taxes | 0 | -0.92 | |||
Ikke-Likvide Ting | 8.38 | 3.04205 | 6.8139 | -10.8456 | 4.91663 |
Cash Taxes Paid | 0 | 0 | 0 | 0 | 0 |
Likvid Rente Betalt | 0.006 | 0.21286 | 0.6003 | 0.67115 | 0.19594 |
Ændringer i Driftskapital | 5.511 | -0.19961 | 0.8712 | 0.24895 | -1.9863 |
Likvider fra Investeringsaktiviteter | 0.095 | -0.102 | -0.23029 | -0.65487 | 11.2389 |
Kapitaludgifter | 0 | -0.102 | -0.24174 | -0.65487 | -0.53757 |
Andre Investerings-Cash-Flow-Ting, Total | 0.095 | 0.01144 | 0 | 11.7764 | |
Likvider fra Financieringsaktiviteter | 78.966 | 20.7929 | 12.6404 | 0 | 26.4127 |
Udstedelse (Pensionering) af Aktier, Netto | 79.591 | 24.5429 | 15.7654 | 0 | 23.8444 |
Udstedelse (Pensionering) af Gæld, Netto | -0.625 | -3.75 | -3.125 | 0 | 2.5683 |
Netto Ændring i Likviditet | 46.943 | 8.44735 | -0.24896 | -10.1541 | 24.345 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Net income/Starting Line | -10.785 | -46.125 | -49.6874 | -28.0449 | -11.5405 |
Cash From Operating Activities | -16.893 | -32.118 | -18.7567 | -9.75913 | -4.28206 |
Cash From Operating Activities | 0.03 | 0.116 | 0.08574 | 0.05554 | 0.02656 |
Non-Cash Items | -6.32 | 8.38 | 31.7794 | 19.2826 | 8.61713 |
Cash Taxes Paid | 0 | 0 | 0 | 0 | 0 |
Cash Interest Paid | 0 | 0.006 | 0.00649 | 0.00649 | 0.60195 |
Changes in Working Capital | 0.182 | 5.511 | -0.93438 | -1.05234 | -1.38523 |
Cash From Investing Activities | 0.095 | 0.09454 | 0.04524 | 0 | |
Capital Expenditures | 0 | 0 | 0 | ||
Cash From Financing Activities | 0 | 78.966 | 78.7678 | 67.4347 | 66.2569 |
Issuance (Retirement) of Stock, Net | 0 | 79.591 | 79.3928 | 68.0597 | 66.8819 |
Issuance (Retirement) of Debt, Net | 0 | -0.625 | -0.625 | -0.625 | -0.625 |
Net Change in Cash | -16.893 | 46.943 | 60.1057 | 57.7208 | 61.9748 |
Other Investing Cash Flow Items, Total | 0.095 | 0.09454 | 0.04524 |
Investornavn | Investortype | Procent udestående | Aktiebeholdning | Aktieændring | Beholdningsdato | IOmsætningsscore |
---|---|---|---|---|---|---|
Level One Partners LLC | Corporation | 9.5157 | 2772643 | 1452337 | 2021-12-31 | |
White Rock Capital Management, L.P. | Hedge Fund | 7.4574 | 2172900 | 852594 | 2021-12-31 | |
Park West Asset Management LLC | Hedge Fund | 5.0561 | 1473218 | 0 | 2022-12-31 | MED |
Hardie Robert D | Individual Investor | 4.0223 | 1172000 | 297000 | 2021-12-31 | |
Green Square Capital Advisors, LLC | Investment Advisor | 3.3874 | 987000 | 794000 | 2022-12-31 | LOW |
Valentino (Michael J) | Individual Investor | 1.6978 | 494690 | 0 | 2022-09-19 | LOW |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 1.4013 | 408320 | 733 | 2022-12-31 | LOW |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 1.1618 | 338522 | -777284 | 2022-12-31 | LOW |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 0.8151 | 237491 | -13361 | 2022-12-31 | LOW |
Ground Swell Capital, LLC | Investment Advisor | 0.751 | 218820 | 176311 | 2022-12-31 | HIGH |
Jane Street Capital, L.L.C. | Research Firm | 0.6607 | 192504 | 192504 | 2022-12-31 | HIGH |
Morgan Stanley Smith Barney LLC | Investment Advisor | 0.6513 | 189785 | -44319 | 2022-12-31 | LOW |
University of Texas Investment Management Company | Endowment Fund | 0.4302 | 125346 | 0 | 2022-12-31 | LOW |
HRT Financial LP | Investment Advisor | 0.2984 | 86942 | 86942 | 2022-12-31 | HIGH |
UBS Financial Services, Inc. | Investment Advisor | 0.2873 | 83723 | 27752 | 2022-12-31 | LOW |
Two Sigma Investments, LP | Hedge Fund | 0.2835 | 82604 | -179302 | 2022-12-31 | HIGH |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 0.2716 | 79132 | 0 | 2022-12-31 | LOW |
Virtu Americas LLC | Research Firm | 0.2449 | 71368 | 71368 | 2022-12-31 | HIGH |
Ergoteles Capital | Hedge Fund | 0.2086 | 60771 | 60771 | 2022-12-31 | HIGH |
Renaissance Technologies LLC | Hedge Fund | 0.187 | 54500 | 54500 | 2022-12-31 | HIGH |
Hvorfor vælge Capital.com? Vores tal taler for sig selv.
Capital.com Group500K+
Handlende
92K+
Månedlkige, aktive klienter
$53M+
Månedlig investeringsvolumen
$30M+
Hævet hver måned
Handelslommeregner
Udregn dit hypotetiske P&L hvis du havde åbnet en CFD-handel på en given dato (vælg en dato) og lukket den på en anden dato (vælg en dato).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
PLx Pharma Inc. Company profile
Om PLx Pharma Inc.
PLx Pharma Inc. er en lægemiddelvirksomhed. Selskabet er fokuseret på sin PLxGuard-platform til lægemiddeloverførsel. Dens kerneprodukt omfatter VAZALORE, der fås i to doser 325 milligram (mg) og 81 mg, er en formulering af aspirin, som klinisk har vist sig at give trombocythæmning til patienter med vaskulære sygdomme og diabetespatienter, der kan være kandidater til aspirinbehandling. PLxGuard-leveringssystemet anvender overfladevirkende lipider, såsom phospholipider og frie fedtsyrer, til at ændre de fysiokemiske egenskaber af forskellige lægemidler med en målrettet frigivelse til udvalgte dele af mave-tarmkanalen. Virksomhedens produktpipeline omfatter også andre orale ikke-steroide antiinflammatoriske lægemidler (NSAID), der anvender PLxGuard-platformen til lægemiddelafgivelse, herunder PL1200 Ibuprofen 200 mg og PL1200 Ibuprofen 400 mg, til smerte- og inflammationsbehandling i klinisk fase I.
Industry: | Pharmaceuticals (NEC) |
9 Fishers Ln Ste E
07871-2402
Resultatopgørelse
- Annual
- Quarterly
Folk ser også
Leder du stadig efter en mægler, du kan stole på?
Deltag sammen med 500.000+ handlende over hele verden, der valgte at handle hos Capital.com